mecamylamine has been researched along with Idiopathic Parkinson Disease in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Excerpt | Relevance | Reference |
---|---|---|
"Pretreatment with nicotine, dose-dependently blocked this toxicity." | 1.38 | Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease. ( Caviedes, P; Cuevas, C; Huenchuguala, S; Muñoz, P; Paris, I; Segura-Aguilar, J; Tizabi, Y; Villa, M, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Muñoz, P | 1 |
Huenchuguala, S | 1 |
Paris, I | 1 |
Cuevas, C | 1 |
Villa, M | 1 |
Caviedes, P | 1 |
Segura-Aguilar, J | 1 |
Tizabi, Y | 1 |
1 other study available for mecamylamine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease.
Topics: Animals; Cell Line; Dicumarol; Dopaminergic Neurons; Dose-Response Relationship, Drug; Indolequinone | 2012 |